Dr. Scott M. Rocklage is not new to healthcare management. The managing partner of 5 AM Ventures has been in the industry from the 70s, holding executive positions in several healthcare organizations. One of his greatest achievements in the industry was achieving the approval of Omniscan™, Cubicin®, and Teslascan® drugs by FDA. This achievement earned him lots of respect across the board, especially given the challenges that come with such approval.
Before joining 5 AM Ventures in 2003, Dr. Scott Rocklage had worked as CEO at Cubist Pharmaceuticals and Nycomed Salutar. He also had the chance to sit on the boards of management for Novira and Relypsa where he at some point served as chairman. Firms, such as Semprus, Miikana, and Ilypsa, also had hired Scott as their executive director in different times. Currently, he has a board membership for Rennovia Pulmatrix and Kinestral among others.
Dr. Scott is a highly qualified scientist, especially in the field of chemistry. His peer-reviewed publications are more than 30 while the patents associated with him are more than 100. He was privileged to attend his Ph.D. class at Massachusetts Institute of Technology (MIT) where his research supervisor was Prof. Richard R. Schrock. Prof. Richard is known for his immense contribution to the field of chemistry that led to his Nobel Prize win. Prior to the Ph.D., he had completed his bachelor’s at the University of California, Berkeley.
Scott is also respected by many for his philanthropic nature. He recently funded the renovation of laboratories at his alma mater, MIT department of chemistry.
Ideamensch featured Dr. Scott recently in an interview. He revealed that 5 AM Ventures derived its name from the word early, given that the organization is an early stage venture capital firm. He also revealed that much of his time is dedicated to the study of life science, although he spares a few hours to attend board meetings. At the office, he mostly rubs shoulders with scientists who seek his guidance on how to develop their research. Business executives also visit his office in search of medical knowledge that would help them grow their entrepreneurship within the pharmaceutical industry.